newport pharmaceuticals &lt;nwph> 3rd qtr loss period ended january 31. shr loss cts profit ct net loss 536,000 profit 166,000 revs 2,099,000 3,149,000 avg shrs 10,429,000 9,943,000 mths shre loss cts loss cts net loss 790,000 loss 377,000 revs 7,089,000 7,646,000 avg shrs 10,406,000 9,351,000 note: full newport pharmaceuticals international inc.